Ettrich, T., Perkofer, L., Berger, A. W., Guethle, M., Behl, S., Zipprich, A., Woerns, M. A., Waldschmidt, D. T., Belle, S., Michl, P., Seufferlein, T. and Dollinger, M. M. (2015). Sorafenib plus Doxorubicin versus Sorafenib alone for advanced hepatocellular carcinoma (Soradox trial): final results of a prospective, randomized, open-label, multicenter phase IIb trial. Eur. J. Cancer, 51. S. S457 - 1. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Ettrich, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Perkofer, L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Berger, A. W.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Guethle, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Behl, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zipprich, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Woerns, M. A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Waldschmidt, D. T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Belle, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Michl, P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Seufferlein, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dollinger, M. M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-393827
DOI: 10.1016/S0959-8049(16)31279-5
Journal or Publication Title: Eur. J. Cancer
Volume: 51
Page Range: S. S457 - 1
Date: 2015
Publisher: ELSEVIER SCI LTD
Place of Publication: OXFORD
ISSN: 1879-0852
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/39382

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item